In the matched non-T2D DXA anchors, semaglutides STEP-1 lean fraction was roughly 3839% of fat-plus-lean loss, while tirzepatides SURMOUNT-1 DXA lean fraction was about 25%. That does not mean muscle loss is inevitable
Additionally, AOD-9604 has been explored for cartilage repair and joint health
Young CL, Britton ZT, Robinson AS: Recombinant protein expression and purification: a comprehensive review of affinity tags and microbial applications
Steroid regulation of somatostatin mRNA in the rat hypothalamus
Numerous experimental peptides currently undergoing clinical and preclinical research target pathways in the body
Although several preclinical anti-cancer outcomes have been achieved, such as with ferroptosis inducers, translating oxidative cell death mechanisms into effective clinical therapies requires rigorous testing, including assessments of bioavailability, toxicity, and off-target effects